|Product Name||LEGENDplex™ SARS-CoV-2 Variants Neut. Ab Panel (5-plex) w/ VbP|
|Description||LEGENDplex™ SARS-CoV-2 Variants Neut. Ab Panel (5-plex) w/ VbP. |
SARS-CoV-2 infection, known as COVID-19, was declared a pandemic in 2020. Among a range of symptoms pulmonary failure can be fatal, which poses a significant threat to global public health. SARS-CoV-2 is a single stranded RNA virus and structurally composed of 4 main proteins (e.g. spike glycoprotein, envelope glycoprotein, membrane glycoprotein and nucleocapsid protein) and several accessory proteins. SARS-CoV-2 continuously evolves as changes in the genetic code occur during replication of the genome. SARS-CoV-2 variants have been emerging and circulating around the world since the beginning of the COVID-19 pandemic, e.g. Alpha (B.1.1.7, first identified in the United Kingdom), Beta (B.1.351, first identified in South Africa), Gamma (P.1, first identified in Brazil), Delta (B.1.617.2, first identified in India), etc. Among the variants, Delta has been defined as Variant of Concern (VOC) for which there is evidence of increased transmissibility and disease severity, significantly decreased neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatment or vaccines.
|Applications||Multiplex - Panel|
|Gene, Accession, CAS #||n/a|
|Order / More Info||LEGENDplex™ SARS-CoV-2 Variants Neut. Ab Panel (5-plex) w/ VbP from BIOLEGEND|
|Product Specific References||n/a|